Latest market price
213.79
-3.82-1.76%
OverviewShort InterestFilings
IBBiShares Biotechnology ETF·NASDAQ
213.79-1.76%
TA
Loading chart...
Screen all →
VXUS+0.27%$82.59VUG-1.21%$84.03VTV+0.24%$228.57VO+0.25%$81.66VGT-2.68%$113.83VB+0.60%$291.80VWO+0.34%$55.70VIG+0.19%$248.24
Fund Snapshot
Category—Asset TypeEquityTagshealthcareReturn% 1Y34.40%Total Holdings243Perf Week2.44%
SponsorISharesETF TypeTagssectorReturn% 3Y24.19%AUM$11.50BPerf Month4.14%
Fund FamilyBond TypeTags—Return% 5Y6.23%NAV/shPerf Quarter12.43%
Index—Average MaturityTags—Return% 10Y52W High222.29 -3.82%Perf Half Y25.64%
Index WeightingCommodity TypeTags—Return% SI52W Low154.62 38.27%Perf YTD26.68%
Active/PassiveQuant TypeTags—Flows% 1M7.59%Volatility2.82% 2.45%Perf Year35.90%
Dividend TTM0.34 (0.16%)ESG TypeTags—Flows% 3M8.41%ATR (14)5.05Perf 3Y85.82%
Dividend Ex-DateSep 15, 2026Dividend TypeSector/ThemeFlows% YTD24.98%RSI (14)56.42Perf 5Y33.42%
Dividend Gr. 3/5Y—Structure TypeRegionFlows% 1YBeta0.71Perf 10Y139.51%
Expense0.44%Growth/ValueSMA202.78%Flows% 3YRel Volume1.23Prev Close217.61
Inverse/LeveragedMarket CapSMA502.57%Flows% 5YAvg Volume1.66MPrice213.79
IPO DateFeb 05, 2001Option/ShortYes / YesSMA20015.58%52W Range %87%Volume2,043,686Change-1.76%
Holdings Breakdown
View Holdings as
Stocks
87.5%Biotechnology
9.6%Life Sciences Tools & Services
2.7%Pharmaceuticals
0.1%Health Care Services
0.1%Health Care Equipment
Bonds, Cash & Other
0.1%Cash and/or Derivatives
Assets Under Management
03.00B6.00B9.00B12.00BAprJunAugOct'25MarMayJulSepNov'26MarMayJulSepNov
● Assets Under Management
Latest News· Times ET
Nov-02-26
Nov-02-2607:21AM
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?zacks.com
Nov-01-26
Nov-01-2610:56PM
Analysis Of Abrdn Healthcare Investors (HQL): The Fund Is Currently OvervaluedSeekingAlpha
Oct-31-26
Oct-31-2604:03PM
$10,000 in Vanguard's Health Care ETF in 2004 Grew to $93,915, and It Still Charges 0.09%247wallst.com
Oct-30-26
Oct-30-2611:18AM
Regeneron Surges 13.55%: Here's What It Means for Your Health Care ETFs247wallst.com
Oct-29-26
Oct-29-2607:20AM
Should You Invest in the iShares Biotechnology ETF (IBB)?zacks.com
Oct-28-26
Oct-28-2612:11PM
ETFs That You May Consider Amid a Strengthening Biotech Outlookzacks.com
Oct-26-26
Oct-26-2609:53AM
Invesco's RSPH or iShares' IBB: Which Healthcare ETF Is the Better Long-Term Buy?fool.com
Oct-24-26
Oct-24-2602:56PM
Biotech stocks are surging. How investors can play the new drug innovation boomcnbc.com
Oct-23-26
Oct-23-2602:23AM
Reported October 22, U.S. Treasury Department Issues Notice Of Proposed Rulemaking For The Outbound Investment Security Program Under The COINS Act; Secretary Has Added Biotechnology To Proposed RegulationsBenzinga
01:41AM
Invesco Pharmaceuticals ETF vs. iShares Biotechnology ETF: Which Is the Better Buy?fool.com
Oct-20-26
Oct-20-2604:25AM
iShares Biotechnology ETF $IBB Shares Sold by Fairvoy Private Wealth LLCdefenseworld.net
Oct-16-26
Oct-16-2612:44PM
Novavax Plunges 12% as Selloff Hits Vaccine Makers; Moderna Tumbles 10%, Pfizer Holds SteadyYahoo
Oct-15-26
Oct-15-2612:55PM
Moderna Rallies 6% as Money Rotates Into Healthcare; BioNTech and Pfizer Edge Higher247wallst.com
Oct-13-26
Oct-13-2603:53PM
Better Buy: Fidelity Health Care ETF (FHLC) or iShares Biotechnology ETF (IBB)?fool.com
10:21AM
From Laggard to Leader: The Surprising Comeback of Healthcareetftrends.com
Fund

The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U.S. biotechnology sector.

Ownership

Per-holder 13F data isn't yet ingested for ETFs — coming with the next data layer expansion.

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR